|
HS Code |
266779 |
| Iupac Name | 3,5-Pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+-)- |
| Molecular Formula | C38H38N4O6 |
| Molecular Weight | 646.73 g/mol |
| Chirality | Racemic mixture ((+-)-) |
| Functional Groups | Amino, Nitro, Ester, Pyridine, Azetidine, Methyl, Isopropyl, Diphenylmethyl |
| Structural Class | Pyridinedicarboxylic acid ester |
As an accredited 3,5-Pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+-)- factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 50-gram amber glass bottle with a secure screw cap and a tamper-evident seal. |
| Container Loading (20′ FCL) | 20′ FCL container is loaded with securely packaged 3,5-Pyridinedicarboxylic acid ester, using drums or cartons for safe chemical transport. |
| Shipping | This chemical is shipped in tightly sealed, chemically resistant containers under ambient conditions. It requires labeling compliant with hazardous material regulations due to potential health risks. Packaging ensures protection from moisture, light, and physical damage. Shipping complies with relevant regional and international safety and environmental guidelines for laboratory and industrial chemicals. |
| Storage | Store 3,5-Pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+/-)- in a tightly sealed container, in a cool, dry, well-ventilated location, away from light, moisture, and incompatible materials such as strong oxidizers and acids. Ensure proper labeling and keep away from heat sources. Store in accordance with standard laboratory chemical safety protocols. |
| Shelf Life | Shelf life: Store in a cool, dry place; stable for 2 years in sealed container under recommended conditions, protect from light. |
Competitive 3,5-Pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+-)- prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing complex molecules brings a set of challenges that don't always see the light; their stories rarely find their way outside of process rooms or spectroscopy reports. As chemists who synthesize 3,5-pyridinedicarboxylic acid derivatives, we've walked those intricate paths more times than we’d care to count—through route selection, crystallization hurdles, and the unique quirks each analog presents. Our product—3,5-pyridinedicarboxylic acid, 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-(1-(diphenylmethyl)-3-azetidinyl) 5-(1-methylethyl) ester, (+-)-—stands as a testament to a very specific branch of custom organic synthesis, reflecting not only hard chemistry but a legacy of careful, accountable work in molecule making.
Every chemical structure tells a story in our field. This compound brings together a pyridine core, diester functionality, amino and methyl groups, and some hefty aromatic systems. You’ll spot the 3-azetidinyl unit and diphenylmethyl substituents not purely for their dramatic molecular influence, but also for the real-world control over reactivity, solubility, and recognition in downstream applications. These aren’t academic decorations; they’re the reasons researchers choose this structure for difficult targets, whether in drug lead exploration or as a scaffold in medicinal chemistry campaigns.
We produce this material as a racemate (+-)-, drawing on robust asymmetric and chiral separation technology when a single enantiomer comes under request. The ability to isolate the forms efficiently changes the game for clients with strict stereochemical needs. As a manufacturer, it takes more than batch records and purity figures—trust builds over years as data consistency supports screening, testing, and process scale-ups without unwelcome surprises.
Inside our facility, staff with hands-on organic synthesis backgrounds guide each step. They’re the ones who check reaction progress at dawn, review NMR traces at night, and handle the unexpected quirks that each batch might introduce—whether it's temperature drift, filtration blockages, or a surprise UV peak that needs investigation. Plenty of companies might claim to source or resell rare compounds, but not many can say they’ve built the route, optimized it, and adapted it over time for life science clients pushing the outer edge of what’s possible.
Producing a structure this complex has taught us the value of deep molecule-level understanding. We’ve invested in in-house NMR, mass spectrometry, and preparative chromatography units not just for QC but for process development and verification at each run. When anomalies show themselves, we have people who’ve seen molecules misbehave before—and know how to coax them back onto the right path.
99+% purity means little if the impurity profile isn’t well understood. We characterize every lot with full NMR, HRMS, IR, and—where necessary—chiral chromatography, not because it looks good on a spec sheet, but because we’ve seen projects stumble when sub-visible isomeric byproducts slip through unchecked. Beyond purity, real reliability includes reproducibility across scales, from gram-scale pilot synthesis to multi-kilogram batches for lead optimization phases, or as synthetic intermediates feeding into downstream analog synthesis.
This compound has moved through medicinal chemistry teams hunting new CNS-active agents, fine-tuning SAR on multi-ring pyridine structures. We’ve sent it to labs developing photoactive materials, where the nitro and methyl substituents provide entry points for further photophysical tuning, and into focused libraries for kinase inhibition studies. These projects rarely follow the same synthetic scripts—adjustments in protecting group strategies, reaction conditions, or final purification routines often arise as collaborators pursue subtle changes in molecular recognition or bioavailability.
Feedback from those teams shapes each new batch. Maybe the amine frees too easily in downstream deblocking; maybe a side product creeps up after a scale jump. Through case-by-case troubleshooting and sometimes real-time process changes, we’ve learned that flexibility and deep familiarity with the molecule’s chemistry mean our partners spend less time diagnosing synthesis headaches and more time chasing the science.
Some ask how this particular ester compares to more generic esters of 3,5-pyridinedicarboxylic acid. A typical methyl or ethyl ester might do for general Suzuki couplings, but in more elaborated scaffolds like this—where the azetidinyl and bulky diphenylmethyl groups dramatically alter electronic and steric behavior—using a generic analogue falls short. These groups block unwanted hydrolysis, prevent side reactions, and modulate solubility enough for the molecule to stay workable in screens, not just on paper but in real-world glassware. Each substituent plays a part, sometimes with surprising consequences—a fact only revealed by direct lab experience.
Our team has taken customer requests to tweak the ester moieties, test stability under harsh coupling conditions, or create derivatives with better solubility for aqueous-based screens. Each time, practice teaches us more about how and why subtle differences matter, especially when scale, time, and budgets turn theoretical possibilities into concrete needs. From synthetic intermediate to final active candidate, these distinctions make a world of difference.
No engineer at our plant builds a production line and walks away. Batch histories remain open to real-time review, and reliable traceability proves its worth every season—especially if a customer returns a year later asking for a matching lot for regulatory filings. Documentation, live process tracking, and open lines between development, QC, and production remain our backbone. Unlike faceless third-party outlets, we answer technical questions with actual synthetic history and, when needed, batch comparison by the same chemists who coordinated the original runs.
Some customers come from regulated industries needing documentation on precursors, solvents, or possible process-related impurities. We keep records not for show, but because regulatory success and reliable downstream synthesis rely on this backbone. Retrospective analysis often reveals new needs—so our archives remain searchable, our analytical protocols openly sharable, and our communication lines responsive.
A molecule this complex never survives scale-up without hands-on trouble-shooting. Recrystallization conditions shift, mixing times need adjustment, and sometimes an innocuous tweak in solvent grade upends a stable process. Every scale jump brings its own lessons. We’ve encountered—and solved—solubility limits in standard solvents, managed chiral drift, optimized for lower residual solvent, and adapted workup techniques to avoid emulsion problems notorious with highly aromatic, functionalized systems.
Molecule-specific experience matters more than any protocol could predict. Choosing the right sequence for deprotection and purification, optimizing for minimal product loss, and controlling polymorphic outcomes are tasks we’ve refined through repeated practice. Our investment in process analytics and the discipline to record every outcome have protected many a project from setbacks that less experienced routes simply would have missed.
Large-scale chemical suppliers treat all molecules as commodities. Our difference comes from lived experience refining this product for sensitive, late-stage research and early process development alike. The presence of a 3-azetidinyl subunit—tricky to introduce using common coupling chemistry—brings challenges in handling and reactivity. The diphenylmethyl group, chosen for its redox stability and size, creates advantages when non-specific hydrolysis or side-chain migration threatens compound integrity. Novelty in structure is not a marketing angle—it’s a hard-won set of tools for scientists who count on results, not catalog entries.
Those attempting to use analogues with less steric protection typically see unwanted side products or lower yields in downstream coupling or cyclization reactions. Our long-form esters reduce byproduct burdens, especially under strong acid or base conditions—critical for medicinal chemistry or intermediates involved in multi-step syntheses.
No two projects use our material in exactly the same way. Some clients report the ester permits smoother peptide coupling on the pyridine ring, avoiding epimerization that dogs more reactive species. Others use the product with customized protecting groups, benefiting from its controlled hydrolysis profile. Each feedback loop shapes our approach; every new request expands our practical knowledge.
Researchers constantly stretch synthesis in new directions. Sometimes a project highlights an unforeseen challenge—a byproduct from an unusual coupling reaction, say, or solubility issues in a formulation prototype. We tackle each head-on, offer our insights, and occasionally develop fresh analytical methods or batch adjustments to keep projects moving. Our best progress comes not from following set protocols, but from solving real-world bottlenecks through a combination of record-keeping, technical experience, and the same day-to-day diligence shown in every production run.
Supporting discovery means more than delivering material; it means troubleshooting at every stage, providing recent data, and offering practical know-how that only comes from real production cycles. We’ve answered analytical questions about impurity trends, stability following storage under different atmospheres, and compatibility with a variety of solvents and reagents. These inquiries aren’t abstract—they’re brought to us by those pioneering new chemical space, and we treat them with the focus they deserve.
When the unexpected strikes, our chemists talk clients through mitigation, sometimes suggesting modifications that save weeks. They’ve troubleshot challenging steps involving the azetidinyl group’s nitrogen, advised on alternative work-up procedures, and offered batch-slippage data upon request. That’s the kind of support that never gets listed on a product page or slipped inside a box, but it keeps research on track when things turn unpredictable.
Complex molecules demand complex stewardship. Waste minimization, solvent recycling, careful handling of nitro and aromatic intermediates—these aren’t just paperwork items. They protect people and the environment, making the process safer both for our staff and for communities downstream. We actively select processes with lower environmental burdens, mitigate risks associated with energetic intermediates, and incorporate safer handling protocols wherever chemistry allows.
We believe open communication and transparent records drive continual improvement, both in yields and in overall process safety. Adapting those lessons into plant upgrades or alternative route scouting remains a continual process informed by real data, not theory. Our people work hands-on, learning from every campaign, and driving evolution not just in our facility’s footprint, but in the chemistry we hand off to the world.
The value of this advanced pyridine compound grows out of technical rigor, adaptiveness, and years of molecule-specific experience. Projects don’t just need a supplier—they benefit from actual manufacturers who have lived the synthetic pathway, managed its hazards, and tuned every aspect until it reliably delivers. That experience comes from scaling up new approaches, troubleshooting alongside partners, and staying transparent through each analytical hurdle.
We see growing demand for this specialty ester, not driven by catalog hype but by results in labs breaking new ground. Their feedback keeps us learning, keeps us listening, and keeps our chemistry practical—making sure each gram produced meets not only purity targets, but also the nuanced needs of real-world applications.
Every kilogram of this pyridinedicarboxylate compound reflects a thousand small decisions—about raw material selection, crystallization points, analytical rigor, and the quiet expertise guiding each production step. We don’t hand off responsibility to anonymous resellers, nor do we treat our work as just another supply-chain transaction. Our approach carries deep respect for the scientific journey. The chemical complexity here is never an obstacle; it’s a toolkit for our collaborators to unlock new horizons in drug design, material science, or any research frontier that calls for this class of structures.
Each new partnership teaches us more, whether through specialized needs for chiral separation, higher-throughput analysis, or real-time troubleshooting. What we’ve learned from years of hands-on synthesis guides every future batch—making us more than just a manufacturer, but a committed partner invested in each scientific outcome.